Quick answer
Cor5 is a company in the Sports Technology / Wearables sector raising capital under Regulation Crowdfunding (Reg CF) through Highlander Crowdfunding, an SEC-registered funding portal. It is offering Common Stock at $1.00 per share, with a minimum investment of $250. As of October 20, 2026, the offering was open to investors.
RegAMagazine does not provide investment advice and does not recommend, endorse or rate any security, issuer or offering. Our profiles are news and educational content only. Inclusion of a company on this site is not a recommendation to buy, sell or hold any security, and nothing here is tailored to your financial situation. Make your own decision after reading the offering documents, and consult a licensed financial professional if you need advice.
At a glance
| Status | Open |
|---|---|
| Sector | Sports Technology / Wearables |
| Exemption | Regulation Crowdfunding (Reg CF) |
| Security | Common Stock |
| Price | $1.00 per share |
| Minimum investment | $250 (250 shares) |
| Valuation | See offering page |
| Target commercial availability | Q1 2027 (per issuer) |
| Raised (current round) | $2,250 |
| Deadline | February 28, 2027 |
| Platform | Highlander Crowdfunding (SEC-registered funding portal, FINRA member) |
The company
Cor5 is developing a dual-mode device that works both as a handheld for quick assessments and as a wearable during training. It combines several physiological sensors — ECG, PPG, multi-frequency bioimpedance, skin temperature and motion — to compare an athlete's readiness, response under load and recovery against their personal baseline.
The company is pre-commercial. Proceeds are earmarked to complete certification, start production and convert signed letters of intent into orders.
What the company says
The following statements come from the issuer's offering materials and have not been independently verified by RegAMagazine:
- Signed letters of intent covering 9,000 units
- Validation pilots completed
- Early-access program open
Questions we'd ask before investing
- Are the letters of intent binding, and at what price per unit?
- Which certifications are still required, and what is the timeline?
- Does the company intend any medical or diagnostic claims that would trigger FDA review?
Key risks
- Pre-revenue hardware company with certification and manufacturing risk.
- Letters of intent are typically non-binding.
- Wearables is a competitive category with large incumbents.
- General Reg CF risks apply: shares are generally restricted from resale for one year, there is usually no market to sell them afterward, and you can lose your entire investment. See our Investor Risk Guide.
Opens the issuer's or SEC's site in a new tab. RegAMagazine does not sell securities or handle investor funds.
RegAMagazine has not received any compensation, in cash, securities or otherwise, from this issuer, Highlander, or any other party in connection with this profile. RegAMagazine may accept compensation for coverage in the future; if it does, this disclosure will be updated to state the amount, form and source of that compensation.
RegAMagazine.com is an independent publication. This profile is for information only. It is not investment advice, and it is not an offer to sell, a solicitation to buy, or a recommendation of any security. Figures and statements are drawn from the issuer's own offering materials on Highlander and have not been independently verified. Investments in Regulation CF and Regulation A offerings are speculative and illiquid, and you may lose your entire investment. Read the issuer's Form C and risk factors before investing.
Data as of October 20, 2026.
Sources
- Issuer offering page on Highlander Crowdfunding: https://app.highlander.ai/pitch-pages/pitch/cor5
- Highlander Crowdfunding, Browse Startups listing: https://www.highlander.ai/browse-startups
- SEC EDGAR full-text search for the issuer's filings: https://www.sec.gov/edgar/search/#/q=%22Cor5%22
Last verified: October 20, 2026. Offering terms change; check the sources above for current figures.
Cite this page
RegAMagazine. "Cor5 Reg CF Offering: Terms, Risks & Profile." RegAMagazine.com, October 20, 2026. https://regamagazine.com/offerings/cor5/